115 related articles for article (PubMed ID: 11332988)
21. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.
Evers R; Kool M; van Deemter L; Janssen H; Calafat J; Oomen LC; Paulusma CC; Oude Elferink RP; Baas F; Schinkel AH; Borst P
J Clin Invest; 1998 Apr; 101(7):1310-9. PubMed ID: 9525973
[TBL] [Abstract][Full Text] [Related]
22. Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4).
Ueda K; Suzuki H; Akiyama S; Sugiyama Y
Jpn J Cancer Res; 1999 Apr; 90(4):439-47. PubMed ID: 10363583
[TBL] [Abstract][Full Text] [Related]
23. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.
Koike K; Kawabe T; Tanaka T; Toh S; Uchiumi T; Wada M; Akiyama S; Ono M; Kuwano M
Cancer Res; 1997 Dec; 57(24):5475-9. PubMed ID: 9407953
[TBL] [Abstract][Full Text] [Related]
24. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.
Toh S; Wada M; Uchiumi T; Inokuchi A; Makino Y; Horie Y; Adachi Y; Sakisaka S; Kuwano M
Am J Hum Genet; 1999 Mar; 64(3):739-46. PubMed ID: 10053008
[TBL] [Abstract][Full Text] [Related]
25. Preparation of anti-mouse caspase-12 mRNA hammerhead ribozyme and identification of its activity in vitro.
Jiang S; Xie Q; Zhang W; Zhou XQ; Jin YX
World J Gastroenterol; 2005 Jul; 11(26):4094-7. PubMed ID: 15996037
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance-associated protein subfamily transporters and drug resistance.
Kuwano M; Toh S; Uchiumi T; Takano H; Kohno K; Wada M
Anticancer Drug Des; 1999 Apr; 14(2):123-31. PubMed ID: 10405639
[TBL] [Abstract][Full Text] [Related]
27. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
Taniguchi K; Wada M; Kohno K; Nakamura T; Kawabe T; Kawakami M; Kagotani K; Okumura K; Akiyama S; Kuwano M
Cancer Res; 1996 Sep; 56(18):4124-9. PubMed ID: 8797578
[TBL] [Abstract][Full Text] [Related]
28. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes.
Kauffmann HM; Keppler D; Kartenbeck J; Schrenk D
Hepatology; 1997 Oct; 26(4):980-5. PubMed ID: 9328323
[TBL] [Abstract][Full Text] [Related]
29. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
[TBL] [Abstract][Full Text] [Related]
30. PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein.
Kocher O; Comella N; Gilchrist A; Pal R; Tognazzi K; Brown LF; Knoll JH
Lab Invest; 1999 Sep; 79(9):1161-70. PubMed ID: 10496535
[TBL] [Abstract][Full Text] [Related]
31. Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2.
Suzuki H; Sugiyama Y
Semin Liver Dis; 1998; 18(4):359-76. PubMed ID: 9875554
[TBL] [Abstract][Full Text] [Related]
32. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.
Materna V; Pleger J; Hoffmann U; Lage H
Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134
[TBL] [Abstract][Full Text] [Related]
33. In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).
Minamino T; Tamai M; Itoh Y; Tatsumi Y; Nomura M; Yokogawa K; Suzuki H; Sugiyama Y; Ohshima T; Miyamoto K
Jpn J Cancer Res; 1999 Oct; 90(10):1171-8. PubMed ID: 10595747
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
[TBL] [Abstract][Full Text] [Related]
35. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
36. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme.
Funato T; Ishii T; Kanbe M; Scanlon KJ; Sasaki T
In Vivo; 1997; 11(3):217-20. PubMed ID: 9239514
[TBL] [Abstract][Full Text] [Related]
37. [ATP-dependent glutathione conjugate export pump].
Furukawa T; Chen ZS; Akiyama S
Nihon Rinsho; 1997 May; 55(5):1083-90. PubMed ID: 9155157
[TBL] [Abstract][Full Text] [Related]
38. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa.
Drenser KA; Timmers AM; Hauswirth WW; Lewin AS
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):681-9. PubMed ID: 9538873
[TBL] [Abstract][Full Text] [Related]
39. Transport of amphipathic anions by human multidrug resistance protein 3.
Zeng H; Liu G; Rea PA; Kruh GD
Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
[TBL] [Abstract][Full Text] [Related]
40. Ribozymes that cleave potato leafroll virus RNA within the coat protein and polymerase genes.
Lamb JW; Hay RT
J Gen Virol; 1990 Oct; 71 ( Pt 10)():2257-64. PubMed ID: 2230733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
